Galmed Pharmaceuticals (GLMD) Non-Current Debt (2013 - 2017)
Galmed Pharmaceuticals (GLMD) posted quarterly Non-Current Debt of $150000.0 for Q2 2017, down 32.43% year-over-year from $222000.0 in Q2 2016, and down 81.16% quarter-over-quarter from $796000.0 in Q4 2016.
Galmed Pharmaceuticals (GLMD) Non-Current Debt (2013 - 2017) Analysis & Trends
Galmed Pharmaceuticals' Non-Current Debt history runs 5 years deep, the most recent figure standing at $150000.0 for Q2 2017.
- In Q2 2017, Non-Current Debt fell 32.43% year-over-year to $150000.0; the TTM figure through Jun 2017 stood at $150000.0 (down 32.43% YoY), while the FY2016 annual figure was $796000.0, up 349.72% from the prior year.
- Non-Current Debt for Q2 2017 stood at $150000.0, down from $796000.0 in the prior quarter.
- The five-year high for Non-Current Debt was $796000.0 in Q4 2016, with the low at $150000.0 in Q2 2017.
- The 5-year median for Non-Current Debt is $311000.0 (2014), against an average of $362166.7.
- The sharpest annual moves came in 2015 and 2016: Non-Current Debt slumped 55.75% in 2015, then jumped 349.72% in 2016.
- Galmed Pharmaceuticals' Non-Current Debt stood at $428000.0 in 2013, then decreased by 6.54% to $400000.0 in 2014, then plunged by 55.75% to $177000.0 in 2015, then surged by 349.72% to $796000.0 in 2016, then tumbled by 81.16% to $150000.0 in 2017.
- Business Quant data shows GLMD's Non-Current Debt at $150000.0 in Q2 2017, $796000.0 in Q4 2016, and $222000.0 in Q2 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 882.16 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 546.77 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 8.96 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 360.97 Mn |
| 10 | Galmed Pharmaceuticals | 2.39 Mn | -9.49 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2017 | 150,000.00 |
| Dec 31, 2016 | 796,000.00 |
| Jun 30, 2016 | 222,000.00 |
| Dec 31, 2015 | 177,000.00 |
| Dec 31, 2014 | 400,000.00 |
| Dec 31, 2013 | 428,000.00 |